Request Sample Inquiry
Structural Biology and Molecular Modeling Market

Structural Biology and Molecular Modeling Market

Structural Biology and Molecular Modeling Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

130

Base Year:

2022

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1333

Segments Covered
  • By Tools By Tools SaaS and Standalone Modeling, Visualization and Analysis, Other Tools
  • By Application By Application Drug Development, Drug Discovery, Other Applications
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 7.02 Billion
Revenue 2030Revenue 2030: USD 24.65 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 17.00%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
Structural Biology and Molecular Modeling Market Share

Market Synopsis:

Global Structural Biology and Molecular Modeling market is valued at USD 7.02 Billion in 2022 and is projected to attain a value of USD 24.65 Billion by 2030 at a CAGR of 17.00% during the forecast period, 2022–2028. The rise in the prevalence of chronic diseases with acquired drug resistance is driving the market, demonstrating the need for novel and enhanced therapies. As a result, there is a great deal of clinical urgency to include Structural Biology and Molecular Modeling tools into the development of novel medications.

COVID-19 pandemic has wreaked havoc on the world's population's health and wreaked havoc on most countries' economies. Due to the fact that social separation is the only available method capable of limiting exposure, the COVID-19 pandemic presents enormous prospects for Structural Biology and Molecular Modeling solutions. Structural Biology and Molecular Modeling, in accordance with this, is an appealing, effective, and cost-efficient solution. Furthermore, this technology is crucial in ensuring the safety of healthcare providers.

Structural Biology and Molecular Modeling Market Size, 2022 To 2030 (USD Billion)

AI (GPT) is here !!! Ask questions about Structural Biology and Molecular Modeling Market
Loading....

Technological Advancements

The emergence of technical breakthroughs has resulted in the development of proven mathematical models that allow for the correct determination of structures and the prediction of cellular functions and interactions, assisting in the identification of novel leads with a higher probability. Furthermore, advances in silico drug design tools, combined with a multidisciplinary approach involving computational biology, molecular biology, and biophysics, are yielding novel methods that aid structural biologists in comprehending diverse protein sequences and accurately predicting protein structures. These unique methods are thought to improve biomedical research and help solve problems, consequently improving drug discovery and increasing demand for modelling tools.

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

  • Real-Time Data Updates:
  • Competitor Benchmarking
  • Market Trends Heatmap
  • Custom Research Queries
  • Market Sentiment Analysis
  • Demographic and Geographic Insights

Get Access Now

High Cost in R&D Activities and Dearth of Skilled Professionals

Data from genomics can be used for a variety of purposes, including pharmacogenomics, diagnostics, and toxicogenomics. The analysis of massive amounts of data generated in genomics research, on the other hand, is a serious difficulty. In some circumstances, technical improvements have made it possible for the instruments in use to give an analysis; nonetheless, the reader's interpretation is still up to them. It is vital to recruit skilled professionals to evaluate and interpret the outcomes of genome sequencing data due to the intricacies involved and the requirement for in-depth understanding in the field of genomics. However, due to a scarcity of qualified individuals, a number of end users are having difficulty processing genomic data.

Market Segmentation:

The Global Structural Biology and Molecular Modeling Market can be segmented by Tools into SaaS and Standalone Modeling, Visualization and Analysis. Based on Application into Drug Development, Drug Discovery, and Other Applications. Based on Region, the Structural Biology and Molecular Modeling Market is segmented into North America, Europe, Asia Pacific, Latin America And Middle East & Africa.

Below tree is interactive. You can click the nodes to get more information.

North America to Continue Dominating the Structural Biology and Molecular Modeling Market

In 2021, North America held the greatest proportion of the Structural Biology and Molecular Modeling market. Factors such as the increased prevalence of chronic illnesses, the need to cut healthcare spending, and the growing general and senior population can all be related to this region's considerable proportion of the worldwide Structural Biology and Molecular Modeling industry. In addition, the growing need to reduce COVID-19 cases, federal mandates to expand healthcare facilities, and a growing focus on improving the quality of care delivered to COVID-19 patients are some of the key factors driving the Structural Biology and Molecular Modeling market's growth in the United States in the aftermath of COVID-19.

Key Players:

Dassault Systèmes (France) , Agile Molecule , Acellera Ltd. (UK), ThermoFisher Scientific (US), Agilent Technologies Inc. (US) are the major companies operating in Structural Biology and Molecular Modeling Techniques Market.

The Structural Biology and Molecular Modeling market is segmented as follows:

Parameter Details
Segments Covered

By Tools

  • SaaS and Standalone Modeling
  • Visualization and Analysis
  • Other Tools

By Application

  • Drug Development
  • Drug Discovery
  • Other Applications

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Dassault Systèmes (France)
  • Agile Molecule
  • Acellera Ltd. (UK)
  • ThermoFisher Scientific (US)
  • Agilent Technologies Inc (US) are the major companies operating in Structural Biology and Molecular Modeling Techniques Market.
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis
Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Explore purchase options

Structural Biology and Molecular Modeling Market is tabulated as follows:

FAQ
Frequently Asked Question
  • The global Structural Biology and Molecular Modeling valued at USD 7.02 Billion in 2022 and is expected to reach USD 24.65 Billion in 2030 growing at a CAGR of 17.00%.

  • The prominent players in the market are Dassault Systèmes (France) , Agile Molecule , Acellera Ltd. (UK), ThermoFisher Scientific (US) , Agilent Technologies Inc (US) are the major companies operating in Structural Biology and Molecular Modeling Techniques Market..

  • The market is project to grow at a CAGR of 17.00% between 2023 and 2030.

  • The driving factors of the Structural Biology and Molecular Modeling include

    • Technological Advancements

  • North America was the leading regional segment of the Structural Biology and Molecular Modeling in 2022.